National and Kapodistrian University of Athens
Κόστος θεραπείας ασθενών με Non-Hodgkin's λέμφωμα μετά από τη διάγνωση και την αρχική θεραπευτική παρέμβαση
Abstract
dc:descriptionNon - Hodgkin's Lymphomas constitute one of the most frequent, malignant diseases of blood, with main representative Diffuse Large B - Cell Lymphomas. Even though, DLBCL is associated with an aggressive natural history; most cases can be cured with combination chemotherapy. The addition of monoclonal antibody Rituximab, to the existing chemotherapy regimens like cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), led to the improvement of survival rates of patients. However, this innovative medicine increased up to a great degree the cost of treatment. This fact in combination with the insufficiency of resources of health care, raised a legitimate question for whether the chemotherapeutic form R- CHOP, has both clinical and eco-nomic effectiveness. In the present study, is carried out a cost - effectiveness analysis of R-CHOP compared to CHOP regimen, in order to show the improvement of sur-vival rates of patients by adding rituximab to the CHOP regimen and its positive ef-fects on the proportional economic indicators of effectiveness, in our country.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Rigopoulou, Dionysia
- Ρηγοπούλου, Διονυσία
Subjects
dc:subject × 21- Μη Hodgkin's λεμφώματα
- Διάχυτο από μεγάλα β-λεμφοκύτταρα λέμφωμα
- Ριτουξιμάμπη
- CHOP-κυκλοφωσφανίδη-αδριαμυκίνη-βινυριστίνη-πρεδνιζόνη
- Κόστος θεραπείας
- Ανάλυση κόστους-αποτελεσματικότητας
- Οικονομία της υγείας
- Αποτελεσματικότητα R-CHOP έναντι CHOP
- Non Hodgkin's lymphomas
- Diffuse large b-cell lymphoma
- Mabthera
- Rituximab
- CHOP-cyclophosphamide-doxorubicin-vincristine-prednisone
- Cost of treatment
- Cost-effectiveness analysis
- Health economics
- Effectiveness of R-CHOP versus CHOP
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28644